TNXP:Tonix Pharmaceuticals Holding Corp Snapshot | Charting | News | Options
$28.37 NASDAQ 8:00a ET
September 18 '25 		Tonix Pharmaceuticals Announces Positive Pre-IND Meeting with FDA for TNX-102 SL for the Treatment of Majo... GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Tonix Pharmaceuticals Announces Positive Pre-IND Meeting with FDA for TNX-102 SL for the Treatment of Major Depressive Disorder
     GlobeNewswire
    Full Story →

    Headline News
    Tonix Pharmaceuticals Announces In-licensing Phase 2/3-Ready Monoclonal Antibody Designed for Seasonal Prevention of Lyme Disease (TNX-4800)
    7:00a ET September 17 '25 GlobeNewswire
    Tonix Pharmaceuticals Presents Clinical Data on Tonmya(TM) for the Treatment of Fibromyalgia at PAINWEEK 2025
    7:00a ET September 8 '25 GlobeNewswire
    Tonix Pharmaceuticals to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2025
    7:00a ET August 28 '25 GlobeNewswire
    More News →
    Day  2.38%Week  0.84%Month  21.30%More Charting →
    September 18 '25. Markets Closed.
    Last $28.37
    Day change   2.38%$0.66
    Open $27.81
    Gap at open $0.10
    Previous close $27.71
    Trading volume 1,297,984
    10 Day avg vol. 1,338,403
    Shares out. 8.8Mil
    Market cap. $248.7Mil
    Trading activity Below Avg.
    Previous data from yesterday, September 17 '25.

    Historical Price Performance
    3 month   12.33% 
    6 month   23.19% 
    1 year   89.26% 
    2 year   98.97% 

    Earnings
    Previous 12m -$39.40
    Next 12m Estimate -$13.02
    P/E ratio --
    Revenue 10Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2025 All rights reserved.